The Rotavirus Organization of Technical Allies (ROTA) Council

Slides:



Advertisements
Similar presentations
Global Alliance for Vaccines and Immunization. n An Alliance u Traditional and new partners u Public and private sector n Partners have in common: u Situation.
Advertisements

Global Measles and Rubella Strategic Plan
From Research to Advocacy
Universal Coverage – Can we guarantee health for all? 3 – 4 October 2011, Kuala Lumpur Nossal perspective.
Global Alliance for Vaccines and Immunization. WHAT IS GAVI ?
Burden of Rotavirus Disease & Impact of Rotavirus Vaccination Umesh D. Parashar, MBBS, MPH Lead, Viral Gastroenteritis Epidemiology Team Centers for Disease.
Update on Vaccines not Included in this Tender: Rotavirus Vaccines Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.
1 |1 | Countries using and planning to introduce IPV.
What is Advocacy? How Can it Help Us Achieve Our Goal?
WHO Global Malaria Programme Technical Expert Groups.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization Department of Chronic Diseases and Health Promotion World Health Organization Gojka Roglic THE GLOBAL BURDEN OF DIABETES AND.
Chemical Industries Council of Malaysia Responsible Care  APEC CHEMICAL DIALOGUE 9th Asia Pacific Responsible Care Conference November 16, 2005 * EDSA.
What is advocacy? How can it help us achieve our goal?
Civil Society in Decision Making for Immunization Policies: the example of National Immunization Technical Advisory Groups (NITAGs) Center for Vaccine.
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
DON MARIANOS, DDS, MPH ORAL HEALTH 2014 INITIATIVE WEBINAR MAY 11, 2012 Prevention & Dental Public Health (DPH) Infrastructure: A State Oral Health Program.
‘Every Newborn’ Country Consultations Country Consultation Objectives Main objective: To provide an opportunity to engage key stakeholders in participatory.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
National Malaria Program Scale-up for Advocacy Based on Impact 23 January 2006.
Promoting patient-centred healthcare around the world Patient Engagement in Patient Safety Jolanta Bilińska Secretary and Governing Board Member IAPO President.
Global Action Plan and its implementation in other regions Meeting for Discussion of the draft Plan for the Implementation of the Global Strategy to Improve.
Accelerated Measles Mortality Reduction Improving Routine Immunization in Africa (AMMRIRIA) - Update Alan Hinman & Samantha Kluglein September 14, 2011.
WCC Presentation Meeting with AMAI (India) 16 February 2012 Alistair Steel, WCC Secretariat.
WHO/OMS Improving and increasing investments in the health outcomes of the poor Macroeconomics and Health in context Dr. Sergio Spinaci, WHO Senegal, February.
Resource Mobilization and Awareness Working Group Mercedes Mas de Xaxás Population Action International.
Can we achieve rotavirus vaccine immunization worldwide by 202X? Global Vaccines 202X: Access, Equity, Ethics May 3, 2011.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Accelerated Measles Mortality Reduction Improving Routine Immunizations in Africa AMMRIRIA Advocacy.
Update on Effectiveness and Safety of Rotavirus Vaccines Umesh D. Parashar Lead, Viral Gastroenteritis Team Centers for Disease Control Prevention Atlanta,
Cochrane Agenda and Priority Setting Methods Group (CAPSMG)
UHC 2030 CSO engagement mechanism Bruno Rivalan IHP+ Northern CSO Representative IHP+ Steering committee 21 th June 2016.
REEEP SOUTH ASIA Partners’ Meeting and Regional Preparatory Meeting John French REEEP Network Director International Secretariat Vienna, Austria. New Delhi,
19th Asia Pacific Regional Conference of ADI
Outline The Global Fund Strategy emphasizes the Key Populations
Impact of Rotavirus Vaccination in Latin America
Community Representative Update
Asia-Pacific Network for the Coordination of Statistical Training
HIMSS Standards Activities
.id briefing – SA population trends
What is quality first??.
Civil Society Consultation Frika Chia Iskandar
ROTAVIRUS COMMON, SEVERE, DEVASTATING, PREVENTABLE
Activity of the High-Level Group for Partnership, Coordination and Capacity Building for Statistics for Agenda 2030 on Sustainable Development (HLG) Gulmira.
COMDIS-HSD Addressing national government priorities
Rotavirus vaccines: Successes and challenges
First East and Central Africa Regional IPC Workshop 11 to 13 October 2016 IGAD/IPC Regional Strategic Engagement, Institutionalization and Work planning.
Funding stigma reduction for key populations: innovation and actions
Head of Policy and Public Affairs
2nd South East Europe Roundtable on Corporate Governance
Launch of the Urban Pathways project
Annual Plan Earlier this week, the SNA Board reviewed the progress we have made to date on the new Strategic Plan that was introduced last year.
Familiarization Meeting
CIPS GLOBAL REACH STRATEGY
PROGRESS BUT MORE NEEDED!
Opportunities for Growth
CHIMS: What does it mean to be a responsible research funder?
PrEP introduction for Adolescent Girls and Young Women
Planning a Learning Unit
Data for Health Initiative in Asia and the Pacific
Define campaign.
Objective of the workshop
Increased Access to Care Logic Model
Nutrition Cluster Advocacy
Social Determinants of Health
The changing nature of UKAID-the Prosperity Fund
COMPREHENSIVE SEXUALITY EDUCATION (CSE) PROVISION
Impact of quality on day-to-day efforts of PHC
Presentation transcript:

The Rotavirus Organization of Technical Allies (ROTA) Council

Goal of the ROTA Council To accelerate the introduction of rotavirus vaccines through the use of evidence and strategic communications targeting policymakers and other key decisions makers 

Chair Core Partners Mathuram Santosham USA Deborah Atherly USA Jon Andrus USA George Armah Ghana Mamadou Ba Senegal Julie Bines Australia Lulu Bravo Philippines Nigel Cunliffe UK Shams El Arifeen Bangladesh Carlo Giaquinto Italy Roger Glass USA Zulkifli Ismail Malaysia Mathuram Santosham USA Core Partners Gagandeep Kang India Li Li China Alexandre Linhares Brazil Erkin Musabaev Uzbekistan Tony Nelson Hong Kong Deborah Atherly USA Umesh Parashar USA Kathleen Neuzil USA Vesta Richardson Mexico Duncan Steele USA Oyewale Tomori Nigeria K. Zaman Bangladesh

Why the ROTA Council is needed Tremendous progress has been made, but more work is needed to reach all children who need these vaccines − particularly those living in low- and middle-income countries in Africa and Asia. That’s where we focus. To date, more than 80 countries have countries have introduced rotavirus vaccines into their national immunization programs. Gavi countries

What the ROTA Council does As credible scientific authorities, we provide evidence for decision making by: Communicating the rotavirus burden and need for prevention Delivering accurate information on vaccine safety and efficacy, underscoring the availability, affordability and life-saving, health-improving potential of vaccines Serving as an independent body for the latest evidence on rotavirus vaccines Working to ensure that vaccines are seen as part of a comprehensive approach to addressing all of diarrhea’s causes

How the ROTA Council works Technical symposia and workshops to update researchers, clinicians, policy-makers, and others on key technical topics around rotavirus, including rotavirus diarrhea, global and regional burden of disease, available vaccines, vaccine impact, costing and financing, etc. Advocacy symposia and workshops to train pediatricians, researchers, and others on effective advocacy strategies for rotavirus vaccines Advocacy and technical materials to support efforts of Council members, partners, vaccine advocates, and others Scientific consensus building among Council members and other key experts on critical technical topics, such as intussusception Media engagement around the need to introduce rotavirus vaccines through commentaries, opinion editorials, and interviews Decision maker engagement to discuss process, key barriers and information needs, and potential plans for introduction with Ministry of Health officials

ROTA Council white paper Intussusception meeting report Recent publications ROTA Council white paper Intussusception meeting report

ROTA Council advocacy toolkit Advocacy resources ROTA Council advocacy toolkit Talking points Fact sheets Data Presentations Reports rotacouncil.org/toolkit